An Evaluation of a Public Health Campaign in a High School Setting Targeting Pain Related Knowledge and Beliefs
Launched by TEESSIDE UNIVERSITY · Nov 23, 2022
Trial Information
Current as of January 13, 2025
Completed
Keywords
ClinConnect Summary
The students will be asked to complete two questionnaires relating to their understanding of pain. One at the start of the conference and one at the end . The first questionnaire will gather demographic information (age, gender, ethnicity and any history of persistent pain). The following questions will be a series of multiple-choice questions relating to beliefs about persistent pain. The second questionnaire to be completed at the end of the day will be identical to the first, minus the demographic questions. Each questionnaire should take 5-10 minutes to complete. So total involvement in...
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: students at one of six schools in Berkshire who had been offered the pain study day.
- • Aged above 16. Providing consent to participate.
- Exclusion Criteria:
- • Students not providing consent.
About Teesside University
Teesside University is a leading higher education institution dedicated to advancing research and innovation in various fields, including healthcare and clinical studies. With a strong emphasis on collaboration and community engagement, the university fosters a dynamic environment for clinical trials that aim to improve patient outcomes and contribute to the body of medical knowledge. Through its state-of-the-art facilities and a multidisciplinary team of researchers, Teesside University actively supports the development and implementation of cutting-edge clinical research initiatives, ensuring adherence to the highest ethical and regulatory standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Reading, Berkshire, United Kingdom
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials